Will Nectome's human preservation protocol be published in a peer-reviewed journal by end of 2028?
One-OffSalute e medicinaScienza2aManifold MarketsSenza KYCDati di risoluzione verificatiDiscretamente calibratoPrevisione della comunità attualeSì 84.3%
Previsori
10
Tipo di domanda
binary
Metodologia
Play-money forecasting platform
Tipo di fonte
Previsione
Dati di mercato
Aggiornato 7 ore fa
Obsoleto18 mar 26, 23:05 UTC31 dic 28, 23:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
Will there be at least one peer-reviewed study correlating AI usage with increased mental illness by end of 2028?
Manifold MarketsDoes Nectome's preservation protocol work?
Manifold MarketsWill a peer-reviewed paper analyzing UAP sensor data be published in a Nature-family journal before January 1, 2027?
Manifold MarketsPeer-reviewed paper in 2026 shows mycelial compounds effective against respiratory diseases?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWill the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?
Manifold MarketsRegole
This market resolves YES if Nectome publishes a peer-reviewed journal article describing their human preservation protocol by December 31, 2028.
- The article must be authored or co-authored by Nectome staff and appear in a journal indexed by PubMed or Web of Science.
- The protocol must describe their procedure for human whole-brain or whole-body preservation, including chemical fixation, cryoprotectant perfusion, and storage methods.
- Resolution sources: PubMed, Web of Science, or the journal's official website.
- Clarification: The protocol does not need to have been experimentally validated on humans in the published paper, merely that it describes the procedure that Nectome intends to use on humans.
- Experimental validation using animal models (e.g., pigs) is sufficient, provided the paper presents the protocol as designed for or compatible with human use.
